Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:12PM ET
0.9277
Dollar change
+0.0377
Percentage change
4.24
%
Index- P/E- EPS (ttm)-0.39 Insider Own7.30% Shs Outstand16.82M Perf Week-7.23%
Market Cap15.60M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.59M Perf Month-24.58%
Income-6.08M PEG- EPS next Q- Inst Own22.67% Short Float0.49% Perf Quarter-22.69%
Sales5.50M P/S2.84 EPS this Y- Inst Trans16.31% Short Ratio0.86 Perf Half Y3.08%
Book/sh0.56 P/B1.66 EPS next Y- ROA-55.95% Short Interest0.08M Perf Year-50.39%
Cash/sh0.42 P/C2.19 EPS next 5Y- ROE-73.15% 52W Range0.70 - 2.13 Perf YTD-25.78%
Dividend Est.- P/FCF- EPS past 5Y-24.30% ROI-60.76% 52W High-56.45% Beta-1.04
Dividend TTM- Quick Ratio4.62 Sales past 5Y24.03% Gross Margin16.11% 52W Low31.78% ATR (14)0.09
Dividend Ex-Date- Current Ratio5.63 EPS Y/Y TTM8.97% Oper. Margin-115.04% RSI (14)40.08 Volatility11.86% 7.82%
Employees62 Debt/Eq0.10 Sales Y/Y TTM-65.80% Profit Margin-110.57% Recom1.00 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q25.83% Payout- Rel Volume0.67 Prev Close0.89
Sales Surprise- EPS Surprise- Sales Q/Q5.74% Earnings- Avg Volume89.57K Price0.93
SMA20-12.62% SMA50-8.71% SMA200-15.45% Trades Volume41,003 Change4.24%
Date Action Analyst Rating Change Price Target Change
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Today 08:19AM
Feb-21-24 08:19AM
Jan-23-24 08:19AM
Jan-16-24 02:51PM
08:19AM
08:30AM Loading…
Dec-20-23 08:30AM
Dec-18-23 07:47AM
Nov-10-23 08:19AM
Nov-08-23 08:19AM
Oct-13-23 01:10PM
06:39AM
Sep-26-23 08:19AM
Sep-22-23 03:05PM
Aug-28-23 08:19AM
Aug-25-23 05:00PM
08:19AM Loading…
Aug-03-23 08:19AM
Jun-21-23 08:19AM
May-18-23 08:19AM
Apr-17-23 07:47AM
Apr-14-23 04:48PM
Mar-08-23 08:19AM
Mar-07-23 04:39PM
Mar-03-23 07:30AM
Mar-02-23 05:15PM
Feb-20-23 05:57AM
Jan-23-23 06:00AM
Jan-13-23 06:39PM
Jan-10-23 08:19AM
Dec-08-22 08:19AM
Dec-01-22 05:12AM
08:19AM Loading…
Nov-02-22 08:19AM
Oct-14-22 10:24AM
09:46AM
09:18AM
Oct-13-22 04:50PM
Oct-11-22 06:25AM
Sep-29-22 08:19AM
Aug-31-22 06:25AM
Aug-30-22 08:19AM
Aug-29-22 04:41PM
Jul-14-22 11:50AM
08:19AM
Jun-23-22 08:19AM
May-16-22 01:20PM
May-12-22 08:19AM
Apr-26-22 08:19AM
Apr-14-22 08:37AM
Feb-08-22 12:27PM
06:39AM
Jan-13-22 08:19AM
Dec-16-21 08:19AM
Dec-03-21 04:32AM
Nov-19-21 08:19AM
Nov-04-21 06:39AM
Oct-29-21 08:19AM
Oct-19-21 06:39AM
Oct-15-21 06:39AM
Oct-12-21 06:11AM
Oct-04-21 04:30PM
Oct-01-21 02:51PM
12:47PM
11:00AM
06:39AM
06:15AM
Aug-30-21 08:19AM
Aug-13-21 01:50AM
Aug-11-21 08:19AM
Aug-05-21 08:19AM
Jul-08-21 11:20AM
Jun-24-21 08:19AM
Jun-23-21 06:53PM
Jun-15-21 08:19AM
Jun-11-21 02:16AM
Jun-04-21 08:00AM
May-27-21 07:15PM
May-12-21 08:30AM
May-11-21 04:38PM
08:19AM
Apr-20-21 09:35AM
Apr-15-21 10:31AM
Apr-07-21 02:33AM
Feb-17-21 12:23AM
Jan-15-21 09:27AM
Jan-13-21 10:26AM
Jan-12-21 08:19AM
Jan-03-21 02:06AM
Dec-16-20 07:05AM
Dec-09-20 08:19AM
Oct-16-20 09:27AM
Oct-05-20 07:16AM
Sep-01-20 08:19AM
Aug-31-20 05:00PM
08:19AM
Aug-25-20 05:51AM
Aug-21-20 06:31AM
Aug-13-20 10:26AM
Aug-12-20 08:19AM
Aug-05-20 11:15AM
Jul-22-20 06:39AM
Jun-29-20 09:39PM
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other. The company was founded in September 1971 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Irani Zackary S.Chief Executive OfficerMay 25 '23Buy1.552003101,020,560May 26 12:23 PM
Irani Zackary S.Chief Executive OfficerMay 24 '23Buy1.615008051,020,360May 26 12:23 PM
Irani Zackary S.Chief Executive OfficerMay 12 '23Buy1.171,7001,9891,019,860May 12 04:39 PM
Irani Zackary S.Chief Executive OfficerMay 10 '23Buy1.275006351,018,160May 12 04:06 PM
Irani Zackary S.Chief Executive OfficerMay 09 '23Buy1.393004171,017,660May 10 05:28 PM
Irani Zackary S.Chief Executive OfficerMay 04 '23Buy1.361,0001,3601,017,360May 05 02:38 PM
Irani Zackary S.Chief Executive OfficerApr 28 '23Buy1.341,8002,4121,017,360May 01 09:15 AM
Irani Zackary S.Chief Executive OfficerApr 27 '23Buy1.312,6003,4061,017,360May 01 09:15 AM
Irani Zackary S.Chief Executive OfficerApr 26 '23Buy1.267,0008,8201,012,960Apr 27 08:55 AM